Sinovac Biotech Net Debt Growth & History (SVA)

Sinovac Biotech's net debt was $17.4M for fiscal 2025.

View full Sinovac Biotech company overview

Sinovac Biotech annual net debt history

Sinovac Biotech annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31$17.4M−$38.7M−69.01%
20242024-12-31$56.0M$881.0M
20232023-12-31−$825.0M$2.98B
20222022-12-31−$3.81B$7.66B
20212021-12-31−$11.47B−$10.55B
20202020-12-31−$916.9M−$776.4M
20192019-12-31−$140.5M$10.5M
20182018-12-31−$151.0M−$69.5M
20172017-12-31−$81.4M−$59.7M
20162016-12-31−$21.7M$19.6M
20152015-12-31−$41.3M−$688,000
20142014-12-31−$40.6M$17.5M
20132013-12-31−$58.2M$29.7M
20122012-12-31−$87.9M

Sinovac Biotech net debt trends

Over the last five fiscal years, Sinovac Biotech's net debt increased from −$916.9M to $17.4M, a change of $934.3M. The latest reported quarter, Q4 2025, shows $17.4M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Sinovac Biotech source filings ↗

Community posts

It’s quiet here.

No posts about SVA yet. Start the conversation.

Write the first post